First Latin America report on the diagnostic utility of the study of the MYD88 L265P gene mutation in patients with Waldenström Macroglobulinemia

Ann Hematol. 2022 Oct;101(10):2365-2367. doi: 10.1007/s00277-022-04910-y. Epub 2022 Jul 7.

Authors

F Giuliani^{1

2}, M A Pavlovsky^{3

4}, I Giere³, I Fernandez^{3

4}, F Sackmann^{3

4}, A Pavlovsky^{3

4}, G Remaggi^{3

4}, J J Castillo⁵

Affiliations

¹ Fundaleu, Haematology Service, Buenos Aires, Argentina. dr.giuliani.franco@gmail.com.
² Centro de Hematologia Pavlovsky, Buenos Aires, Argentina. dr.giuliani.franco@gmail.com.
³ Fundaleu, Haematology Service, Buenos Aires, Argentina.
⁴ Centro de Hematologia Pavlovsky, Buenos Aires, Argentina.
⁵ Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

PMID: 35794278
DOI: 10.1007/s00277-022-04910-y

No abstract available

Publication types

Letter

MeSH terms

Humans
Latin America / epidemiology
Lymphoma, B-Cell*
Mutation
Myeloid Differentiation Factor 88 / genetics
Waldenstrom Macroglobulinemia* / diagnosis
Waldenstrom Macroglobulinemia* / genetics

Substances

Myeloid Differentiation Factor 88